Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study

Baseline P-selectin but not D-dimer levels predict recurrent VTE and may be a valuable addition to clinical prediction rules to select patients for more intensive therapy or closer observation.